News

Researchers have identified a specific class of bacteria from the gut that prevents mice from becoming obese, suggesting these same microbes may similarly control weight in people.

Researchers have developed new molecules that can silence or inhibit malfunctioning miRNA, with the hope that their work could lead to new ways to treat diseases which are caused by the miRNAs.

Chemical engineers have developed a new class of high-performance membranes for carbon capture that greatly exceed current targets.

The world's food supply will become safer as the food industry shifts to high-resolution, whole-genome sequencing - which examines the full DNA of a given organism all at once. This move to make sequencing ubiquitous will lead to the consistently reliable detection of salmonella.

In 2018, the United States packaged food and beverage supply was ultra-processed and generally unhealthy found a study. Consequently Americans are over-exposed to products that are high in calories, saturated fat, sugar and salt.

Melanoma skin cancer incidence rates have soared by 45% since 2004 according to the latest figures released by Cancer Research UK.

Old-school Hollywood editors cut unwanted frames of film and patched in desired frames to make a movie. The human body does something similar--trillions of times per second--through a biochemical editing process called RNA splicing. Rather than cutting film, it edits the messenger RNA that is the blueprint for producing the many proteins found in cells.

Researchers have developed an easily reproducible system that enables them to keep slices of human hearts alive for a longer period of time, allowing more extensive testing of new drugs and gene therapies.

Researchers have discovered precisely why inactive LKB1 results in lung cancer development. Their new paper highlights how LBK1 communicates with two enzymes that suppress inflammation in addition to cell growth, to block tumor growth. These findings could lead to new therapies for NSCLC.

Scientists have identified a new type of cell called a hepatobiliary hybrid progenitor (HHyP), that forms during our early development in the womb. Surprisingly, HHyP also persists in small quantities in adults and these cells can grow into the two main cell types of the adult liver (Hepatocytes and Cholangiocytes) giving HHyPs stem cell-like properties.